Molecular Diagnostics Market: Global Industry Trends, Share, Size and Forecast Report 2022-2031

Molecular diagnostic tests are wont to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, etc. to further diagnose the disease. These are cumulative techniques for analyzing biological markers at the molecular level, like genome and proteome. These techniques are used for diagnosis of the varied infectious diseases, cancer, etc. and is additionally wont to check the genetic predisposition to a disease. Molecular diagnostic tests are the elementary a part of a successful health care system. Molecular diagnostic tests deliver critical information that helps the healthcare providers and patients to form the proper medical decisions for better outcome of a procedure.

The global molecular diagnostics market is expected to be around USD 13.54 Billion by 2025 at a CAGR of 8.5%

Nevertheless, the rising prevalence of the communicable disease, growing awareness regarding molecular diagnostic techniques, and advancement in molecular diagnostics are the first factors liable for market growth during the forecast period. The increasing prevalence of infectious diseases, rising incidence of various sorts of cancer, and advancements in molecular diagnostic techniques are the main drivers propelling market growth. Nevertheless, stringent regulatory policies constrain the expansion of the market.

The global Molecular Diagnostics market is segregated on the basis of Application as Genetic Tests, Other Applications, Oncology, and Infectious Diseases. Based on Technology the global Molecular Diagnostics market is segmented in in Situ Hybridization, DNA Microarray, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, and Other Technologies. Based on Product & Service the global Molecular Diagnostics market is segmented in Instruments, Services & Software, and Reagents & Kits. Based on End User, the global Molecular Diagnostics market is segmented in Reference Laboratories, Hospital & Academic Laboratories, and Other End Users.

Get a Sample Copy of this Report with Graphs and Charts:

The global Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, and others are among the major players in the global Molecular Diagnostics market.

The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

Molecular Diagnostics Market has been segmented as below:

Molecular Diagnostics Market, By Application

Genetic Tests
Other Applications
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Infectious Diseases
Other Infectious Diseases

Molecular Diagnostics Market, By Technology

in Situ Hybridization
DNA Microarray
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-Generation Sequencing
Other Technologies

Molecular Diagnostics Market, By Product & Service

Services & Software
Reagents & Kits

Molecular Diagnostics Market, By End User

Reference Laboratories
Hospital & Academic Laboratories
Other End Users

Molecular Diagnostics Market, By Region

North America
Rest of the World

Molecular Diagnostics Market, By Company

Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation

Request to Fill The Form To get Sample Copy of This Report:

The report covers:

Global Molecular Diagnostics market sizes from 2015 to 2024, along with CAGR for 2018-2024
Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
Global Molecular Diagnostics market trends, covering comprehensive range of consumer trends & manufacturer trends Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global
Molecular Diagnostics market Major market opportunities and challenges in forecast timeframe to be focused
Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
Comprehensive company profiles of the key industry players

Report Scope:

The global Molecular Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Molecular Diagnostics market share. Major industry players with significant revenue share include Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, and others.

Reasons to Buy this Report:

Gain detailed insights on the
Molecular Diagnostics industry trends
Find complete analysis on the market status
Identify the
Molecular Diagnostics market opportunities and growth segments
Analyse competitive dynamics by evaluating business segments & product portfolios
Facilitate strategy planning and industry dynamics to enhance decision making

Some of the recent Developments in Molecular Diagnostics market are as follows:

Thermo Fisher Scientific

MAR 03 2020 – Thermo Fisher Scientific to Acquire QIAGEN N.V.
July 08, 2020- Thermo Fisher Scientific Signs Companion Diagnostic Contract with Chugai Pharmaceutical

Abbott Laboratories

March 27, 2020- Abbott Launches Molecular Point-Of-Care Test to Detect Novel Coronavirus in As Little as Five Minutes.
March 18, 2020- Abbott has received emergency use authorization from the FDA for its molecular test for the identification of SARS-CoV-2, the virus that causes COVID-19.

Europe, Middle-East and Africa Riot Control Equipment Market
Military Radars Market
Armored Vehicles Upgrade and Retrofit Market
Satellite Manufacturing and Launch Systems Market
Commercial Aircraft Seating Market
Piston Engine Aircraft Market
Military Satellite Market
Latin America Inflight Entertainment and Connectivity Market
Mortar Ammunition Market
Land-based C4ISR Market
Air Traffic Control Equipment Market
Submarine Market
Soldier Modernization Market

Related posts

Leave a Comment